Table 4: Operational recommendations.
Scenario |
Anticoagulant choice |
|
Processing≤2hours |
K₃EDTA |
Prioritize platelet studies |
Delays(2-6hours) |
K₂EDTA |
AdjustMCV/RDW-SD referenceranges |
All workflows |
N/A |
Document storage duration/anticoagulant < brr > - |